Navigation Links
Less-Invasive Surgery for Esophageal Cancer Might Be Safer
Date:4/30/2012

MONDAY, April 30 (HealthDay News) -- Besides being easier on the patient, minimally invasive surgery to remove the esophagus of patients with esophageal cancer can also greatly reduce the risk of lung infection compared to traditional open surgery, a new study finds.

Dutch researchers also found that patients who undergo this less-invasive procedure have much shorter hospital stays and a better short-term quality of life than those who have open surgery, which requires cutting through a patient's chest.

One U.S. expert was impressed with the findings. The study "goes a long way to encouraging esophageal surgeons to seriously consider minimally invasive surgery for their patients with surgically resectable [removable] esophageal cancers," said Dr. Jonathan Aviv, clinical director of the Voice and Swallowing Center at Mount Sinai Medical Center in New York City.

Removal of part of or the entire esophagus (a procedure called esophagectomy) is the mainstay of esophageal cancer treatment. This study compared open esophagectomy and minimally invasive esophagectomy.

The minimally invasive procedure was first used two decades ago but this is the first study to compare minimally invasive and open esophagectomy, according to Miguel Cuesta, of the VU University Medical Centre in Amsterdam, and colleagues.

The researchers looked at the outcomes of 56 patients who had open surgery and 59 patients who had the minimally invasive procedure. In the two weeks after surgery, lung (or pulmonary) infections occurred in 29 percent of those who had open surgery but only 9 percent of those who had minimally invasive surgery.

Overall, 34 percent of the patients who had open surgery developed a lung infection, compared with 12 percent of those who underwent minimally invasive surgery, the study found.

The researchers also noted that patients who had minimally invasive surgery had less blood loss, far shorter hospital stays, and better quality of life (much less pain and vocal-cord paralysis).

Importantly, minimally invasive surgery was as effective as open surgery, the study authors concluded in the report published online April 30 in The Lancet.

"If these results can be confirmed in other settings, minimally invasive esophagectomy could truly become the standard of care," Simon Law, of the University of Hong Kong, China, wrote in an accompanying editorial.

For his part, Aviv also believes that the study "underscores the need for continued early screening of patients with symptoms suggestive of esophageal cancer -- cough and hoarseness, likely even more important than 'typical' gastrointestinal symptoms such as heartburn and regurgitation."

Aviv, who is also clinical professor of otolaryngology at Mount Sinai Medical Center, added that "esophageal cancer both in western Europe and here in the USA is the only cancer that is markedly increasing in incidence the past 30 years."

More information

The U.S. National Cancer Institute has more about esophageal cancer.

-- Robert Preidt

SOURCES: Jonathan E. Aviv, M.D., F.A.C.S., clinical director, Voice and Swallowing Center ENT and Allergy Associates, and clinical professor, otolaryngology, Mount Sinai Medical Center, New York City; The Lancet, news release, April 30, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Less-invasive Lymph Node Resection Following Breast Cancer Surgery Confirmed as Standard of Care in Eight-year Study Led by AGH Doctors
2. Repeated Weight-Loss Surgery Carries Added Risks
3. The New Liposuction Technique Means No Surgery or Suction
4. Research validates surgery alone offers reasonable overall survival for stage I SCLC
5. "New Cosmetic Surgery" Journalism Prize
6. Abington Memorial Hospital Welcomes Vakil to Orthopaedic Surgery Division
7. Drug for advanced kidney cancer shrinks tumors prior to surgery
8. Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM)
9. New endoscopic treatment may spare Barretts esophagus patients from surgery
10. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
11. Surgery Alone May Thwart Stage 1 Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Less-Invasive Surgery for Esophageal Cancer Might Be Safer
(Date:5/31/2016)... ... , ... Spectrum Aquatics has launched a brand new ADA pool lift, the ... the user in mind. , “Over the last two years our key customers and ... lbs lift is a necessary requirement for certain facilities with specific needs,” said Nabil ...
(Date:5/31/2016)... Clearwater, FL (PRWEB) , ... May 31, 2016 , ... ... for its innovative herbal energy pouches, on World No Tobacco Day . ... in select retail locations later on this summer. , The new flavor is ...
(Date:5/31/2016)... IL (PRWEB) , ... May 31, 2016 , ... ... multichannel marketing services firm and statement solutions provider, for the tenth ... in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in ...
(Date:5/30/2016)... ... 30, 2016 , ... As the CDC relaxes its stance on traditional No-Nit ... keep their households lice free. , According to a May 26 article from ... kids in the classroom despite the fact that they may be harboring an infestation. ...
(Date:5/30/2016)... ... May 30, 2016 , ... Another ER facility operated by First Choice ... Legacy Drive, Plano, TX and is open 24 hours daily. , First Choice Emergency ... medical open house. The Jasper High School band entertained attendees and accepted First Choice ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... Eye expert s ... eye examination before leaving hospital ... Moorfields Eye Hospital Dubai, the first overseas branch of the ... identified premature babies as a special concern in the region when ... retinopathy of prematurity (ROP). ROP is a potentially blinding condition that ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
Breaking Medicine Technology: